ESC 365 - When is percutaneous approach the ideal therapeutic strategy?

HFA Premium Access

When is percutaneous approach the ideal therapeutic strategy?

Session: Heart failure and coronary artery disease: medicate? dilate? or operate?

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Speaker: Professor M. Petrie (Glasgow, GB)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Professor Mark C Petrie

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

51 presentations

9 followers

3 more presentations in this session

Why is CAD underdiagnosed in ADHF patients?

Speaker: Professor H. Skouri (Beirut, LB)

Medical treatment or surgical revascularisation in HF of ischaemic aetiology?

Speaker: Doctor J. Bartunek (Aalst, BE)

Heart failure and coronary artery disease: medicate? dilate? or operate? - discussion

Access the full session

Heart failure and coronary artery disease: medicate? dilate? or operate?

Speakers: Professor M. Petrie, Professor H. Skouri, Doctor J. Bartunek

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources